Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?

Eur Respir Rev. 2021 Nov 17;30(162):210103. doi: 10.1183/16000617.0103-2021. Print 2021 Dec 31.

Abstract

In people with cystic fibrosis (PwCF), viscous sputum and dysfunction of the mucociliary escalator leads to early and chronic infections. The prevalence of Aspergillus fumigatus in sputum is high in PwCF and the contribution of A. fumigatus to the progression of structural lung disease has been reported. However, overall, relatively little is known about the contribution of A. fumigatus to CF lung disease. More knowledge is needed to aid clinical decisions on whether to start antifungal treatment. In this review, we give an overview of A. fumigatus colonisation and infection in PwCF and the different types of pulmonary disease caused by it. Furthermore, we discuss the current evidence for structural lung damage associated with A. fumigatus in PwCF on chest computed tomography and magnetic resonance imaging. We conclude that radiological outcomes to identify disease caused by A. fumigatus can be important for clinical studies and management.

Publication types

  • Review

MeSH terms

  • Aspergillus fumigatus
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Cystic Fibrosis* / diagnosis
  • Cystic Fibrosis* / diagnostic imaging
  • Humans
  • Prevalence
  • Sputum

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator